糖心vlog

[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
糖心vlog Home
JAMA
Sign In
New Online Current Issue Past Issues
糖心vlog Statement on Potentially Offensive Content

November 2024 - July 1883

Decade

Year

Issue

June 27, 2023, Vol 329, No. 24, Pages 2109-2202

This Week in JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2023;329(24):e2215953. doi:10.1001/jama.2022.15953
  • Podcast: DAPT vs tPA for Minor Stroke, Transgender Identity and Suicide, Screening for Anxiety, and more
Original Investigation

Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial

Hui-Sheng Chen, MD; Yu Cui, PhD; Zhong-He Zhou, MD; et al.
Abstract Full Text
free access
JAMA. 2023;329(24):2135-2144. doi:10.1001/jama.2023.7827

This randomized trial examines whether dual antiplatelet therapy is noninferior to intravenous thrombolysis among patients with minor nondisabling acute ischemic stroke.

Transgender Identity and Suicide Attempts and Mortality in Denmark

Annette Erlangsen, PhD; Anna Lund Jacobsen, BSc; Anne Ranning, PhD; et al.
Abstract Full Text
free access
JAMA. 2023;329(24):2145-2153. doi:10.1001/jama.2023.8627

This nationwide cohort study in Denmark examines the association between individuals who identify as transgender and rates of suicide attempt and mortality (suicide, unrelated, and all cause).

Preliminary Communication

Translational Science

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome

Ann-Christin Pecher, MD; Luca Hensen, PhD; Reinhild Klein, MD; et al.
Abstract Full Text
free access
JAMA. 2023;329(24):2154-2162. doi:10.1001/jama.2023.8753

This case report summarizes treatment of a patient with antisynthetase syndrome using CD19-targeting T cells against B cells and plasmablasts.

Research Letter

Transition From Mentored to Independent NIH Funding by Gender and Department

Mytien Nguyen, MS; Aanya Panyadahundi; Christine Olagun-Samuel, BA; et al.
Abstract Full Text
free access
JAMA. 2023;329(24):2189-2190. doi:10.1001/jama.2023.7693

This study uses National Institutes of Health RePORTER data for mentored K awards and R01-equivalent grants to all departments in US schools of medicine to characterize K-award distribution and K-to-R transition by gender and department between 1997 and 2021.

Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020

Angela C. Weyand, MD; Alexander Chaitoff, MD, MPH; Gary L. Freed, MD, MPH; et al.
Abstract Full Text
free access
JAMA. 2023;329(24):2191-2193. doi:10.1001/jama.2023.8020

This study examines prevalence of iron deficiency among females aged 12 to 21 years to inform future screening strategies for iron deficiency and iron-deficiency anemia.

US Preventive Services Task Force

Recommendation Statement

Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force
Abstract Full Text
free access has active quiz has audio
JAMA. 2023;329(24):2163-2170. doi:10.1001/jama.2023.9301

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety disorders in adults, including pregnant and postpartum persons (B recommendation), and concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults (I statement).

  • Podcast: USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults

Evidence Report

Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force

Elizabeth A. O鈥機onnor, PhD; Michelle L. Henninger, PhD; Leslie A. Perdue, MPH; et al.
Abstract Full Text
free access has active quiz has audio
JAMA. 2023;329(24):2171-2184. doi:10.1001/jama.2023.6369

This systematic review to support the 2023 US Preventive Services Task Force Recommendation Statement on anxiety screening summarizes published evidence on the benefits and harms of screening for, and treatment of, anxiety among primary care patients.

  • Podcast: USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults
Viewpoint

The Mifepristone Case and the Legitimacy of the FDA

Abbe R. Gluck, JD
Abstract Full Text
JAMA. 2023;329(24):2121-2122. doi:10.1001/jama.2023.8712

This Viewpoint discusses a recent federal court decision that invaliated the Food and Drug Administration鈥檚 (FDA) approval of mifepristone, a drug used to end pregnancies and manage miscarriage when used with misoprostol, and how that decision challenges the legitimacy and independence of the FDA.

Normothermic Regional Perfusion鈥擳he Next Frontier in Organ Transplants?

Robert D. Truog, MD; Andrew Flescher, PhD; Keren Ladin, PhD, MSc
Abstract Full Text
JAMA. 2023;329(24):2123-2124. doi:10.1001/jama.2023.9294

This Viewpoint examines an approach known as normothermic regional perfusion, involving use of ECMO to restore perfusion to internal organs in situ before they are removed from a deceased donor.

Congress鈥� Misguided Plan to Ban QALYs

Leah Z. Rand, PhD; Adam Raymakers, PhD; Benjamin N. Rome, MD, MPH
Abstract Full Text
JAMA. 2023;329(24):2125-2126. doi:10.1001/jama.2023.8695

This Viewpoint discusses the flawed assumptions and potential negative impacts of a proposed federal bill that would ban government health care programs from using the quality-adjusted life-year (QALY) and 鈥渟imilar measures鈥� when determining insurance coverage or negotiating prices.

Pediatric Drug and Other Shortages in the Age of Supply Chain Disruption

Carmel Shachar, JD, MPH; Philip A. Gruppuso, MD; Eli Y. Adashi, MD, MS
Abstract Full Text
JAMA. 2023;329(24):2127-2128. doi:10.1001/jama.2023.4755

This Viewpoint lists the top 3 pediatric drugs and product shortages, considers the federal government鈥檚 and manufacturers鈥� ethical duty to protect children, reviews the causes for the shortages, and suggests policy changes that could help fill in the gap.

A Piece of My Mind

An Apple a Day

Emily Landon, MD
Abstract Full Text
JAMA. 2023;329(24):2129. doi:10.1001/jama.2023.8957

In this narrative medicine essay, an infectious diseases physician compares her past near bucolic experience in the emergency department when treated for anaphylaxis with the now perpetually chaotic and crowded scene ushered in by COVID-19.

Editorial

CD19-Targeting CAR T-Cell Therapy for Antisynthetase Syndrome

Ingrid E. Lundberg, MD, PhD; Angeles S. Galindo-Feria, MD, PhD; Begum Horuluoglu, PhD
Abstract Full Text
JAMA. 2023;329(24):2130-2131. doi:10.1001/jama.2023.7240

Are There Reasons to Fear Anxiety Screening?

Murray B. Stein, MD, MPH; Linda L. Hill, MD, MPH
Abstract Full Text
free access has audio
JAMA. 2023;329(24):2132-2134. doi:10.1001/jama.2023.7239
  • Podcast: USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults
JAMA Insights

Genomics and Precision Health

siRNAs鈥擜 New Class of Medicines

Anastasia Khvorova, PhD
Abstract Full Text
has active quiz
JAMA. 2023;329(24):2185-2186. doi:10.1001/jama.2023.4570

This Genomics and Precision Health article explains how small interfering RNA can modulate disease targets considered 鈥渦ndruggable鈥� by small molecules and biologics.

JAMA Clinical Challenge

Diffuse Cutaneous Eruption

Katharina S. Shaw, MD; Stephanie Sanchez-Melendez, BS; Ruth Ann Vleugels, MD, MPH, MBA
Abstract Full Text
has active quiz
JAMA. 2023;329(24):2187-2188. doi:10.1001/jama.2023.7322

A man presented with a pruritic cutaneous eruption that began on his scalp and face and over 2 months spread across most of his body. Physical examination revealed confluent salmon-colored plaques with areas of unaffected skin; waxy, exfoliative scale on the volar aspect of the hands and feet; and ectropion. He had no history of psoriasis, atopic dermatitis, or other skin disorder, and no recent viral or bacterial infection. What is the diagnosis and what would you do next?

Editor's Note

Poetry in a Head CT

Rafael Campo, MD, MA
Abstract Full Text
free access
JAMA. 2023;329(24):2197. doi:10.1001/jama.2023.10520
Medical News & Perspectives

COPD Mortality, Goals-of-Care Conversations in Serious Illness, and Advocating for Climate Change Science and Gun Violence Prevention鈥擧ighlights From the American Thoracic Society Conference

Kristin Walter, MD, MS
Abstract Full Text
has audio
JAMA. 2023;329(24):2114-2115. doi:10.1001/jama.2023.4390

This Medical News article is an interview with Debra Boyer, MD, MHPE, chair of the 2023 American Thoracic Society Conference.

  • Podcast: Highlights From the American Thoracic Society 2023 Conference

Public Health Experts Advise Clinicians to Be on the Lookout for New Mpox Cases

Preeti N. Malani, MD, MSJ
Abstract Full Text
free access
JAMA. 2023;329(24):2116-2117. doi:10.1001/jama.2023.9500

This Medical News article discusses signs of an mpox resurgence and updated prevention and treatment information.

Medical News in Brief

Decline in New HIV Cases Projected to Fall Short of US Goals

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2118. doi:10.1001/jama.2023.9924

FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment

Emily Harris
Abstract Full Text
free access
JAMA. 2023;329(24):2118. doi:10.1001/jama.2023.9925

Surgeon General Urges Action to Improve Social Media Safety for Kids

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2118. doi:10.1001/jama.2023.9926

CMS Rule Would Increase Cost Transparency of Medicaid-Covered Drugs

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2118. doi:10.1001/jama.2023.9927

Brain Cell Biomarker for Preclinical Alzheimer Disease Identified

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2118-2119. doi:10.1001/jama.2023.9928

Extended-Release Buprenorphine Receives FDA Green Light

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2119. doi:10.1001/jama.2023.9929

Review Finds Benefits of Primary Care Continuity

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2119. doi:10.1001/jama.2023.9930

鈥淐are Bundle鈥� Improved Outcomes for Patients With Brain Bleeds

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2119. doi:10.1001/jama.2023.9931

No Difference in Quality, Cost for Patients Treated by Hospitalist MDs vs DOs

Emily Harris
Abstract Full Text
JAMA. 2023;329(24):2119. doi:10.1001/jama.2023.9932
The Arts and Medicine

Gaudeamus Igitur at 40鈥擜 Tribute and Assessment

Elizabeth A. Fleming, MD; Brittany A. Bettendorf, MD, MFA
Abstract Full Text
JAMA. 2023;329(24):2111-2113. doi:10.1001/jama.2023.9330

This Arts and Medicine feature discusses the continuing relevance of the 1983 poem Gaudeamus Igitur by John Stone, which offers wisdom and guiding principles about the practice of medicine to newly graduated young physicians.

Poetry and Medicine

Innumerable

Joseph Gascho, MD
Abstract Full Text
JAMA. 2023;329(24):2197. doi:10.1001/jama.2023.8852
JAMA Revisited

International Mental Health

Abstract Full Text
JAMA. 2023;329(24):2198. doi:10.1001/jama.2022.15954
JAMA Patient Page

Screening for Anxiety Disorders in Adults

Jill Jin, MD, MPH
Abstract Full Text
free access has audio
JAMA. 2023;329(24):2202. doi:10.1001/jama.2023.9446

This JAMA Patient Page describes the pros and cons of screening for anxiety disorders in adults.

  • Podcast: USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults
Comment & Response

California鈥檚 State Insurance Gender Nondiscrimination Act and Utilization of Gender-Affirming Surgery

Rishub K. Das, BA; Brian C. Drolet, MD
Abstract Full Text
JAMA. 2023;329(24):2193. doi:10.1001/jama.2023.7928

California鈥檚 State Insurance Gender Nondiscrimination Act and Utilization of Gender-Affirming Surgery鈥擱eply

Anna Schoenbrunner, MD; Annamarie Beckmeyer, JD; Adrian Diaz, MD, MPH
Abstract Full Text
JAMA. 2023;329(24):2193-2194. doi:10.1001/jama.2023.7931

The White House鈥檚 Strategic Plan to Address the Opioid Crisis

Nastassja Michel, BS; Julianne E. G. McGough, BS; Rachel M. A. Linger, PhD
Abstract Full Text
JAMA. 2023;329(24):2194. doi:10.1001/jama.2023.8239

The White House鈥檚 Strategic Plan to Address the Opioid Crisis

Barbara H. Chaiyachati, MD, PhD; Emily Bosk, PhD, LMSW; Davida M. Schiff, MD, MSc
Abstract Full Text
JAMA. 2023;329(24):2194-2195. doi:10.1001/jama.2023.8242

The White House鈥檚 Strategic Plan to Address the Opioid Crisis鈥擱eply

Michael A. Incze, MD, MSEd; Taylor Kelley, MD, MPH, MSc; Phillip M. Singer, PhD, MHSA
Abstract Full Text
JAMA. 2023;329(24):2195. doi:10.1001/jama.2023.8245
Correction

Error in Text Wording and Incorrect Reference

Abstract Full Text
free access
JAMA. 2023;329(24):2196. doi:10.1001/jama.2023.10533

Incorrect Wording

Abstract Full Text
free access
JAMA. 2023;329(24):2196. doi:10.1001/jama.2023.10589
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2023;329(24):2109-2110. doi:10.1001/jama.2022.15952

Latest from the USPSTF

View more >
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
View more
View more
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)鈥�
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)鈥�
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy